Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-27

Clinical Trial Update: RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a maternal immunization RSV F vaccine in healthy third-trimester pregnant women (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSV F vaccine (RSV F protein vaccine)

Snippet

Sponsor: Novavax | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED